CANCER 2026 Laure Talarmain
Peter MacCallum Cancer centre, VICTORIA, Australia
Presentations this author is a contributor to:
Clonal heterogeneity of drug tolerant persisters following targeted therapy in non-small cell lung cancer (#241)
5:35 PM
Sunniyat Rahman
Poster Session 2
Temporal single clone analyses reveal a Xlr4b driven HSPC program that facilitates T-cell reconstitution following transplantation. (#270)
5:35 PM
Elanor N Wainwright
Poster Session 2